Ricardo Attar Selected Research

BMS 641988

8/2015

Discovery of BMS-641988, a Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ricardo Attar Research Topics

Disease

3	Neoplasms (Cancer) 12/2021 - 01/2019
3	Multiple Myeloma 01/2020 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 10/2009
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2019
1	Carcinogenesis 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 08/2015

Drug/Important Bio-Agent (IBA)

2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2020 - 01/2020
1	Phosphotransferases (Kinase)IBA 12/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	AntigensIBA 01/2020
1	blinatumomabIBA 01/2020
1	B-Cell Maturation AntigenIBA 01/2020
1	Bispecific AntibodiesIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2019
1	bicalutamide (Casodex)FDA LinkGeneric 08/2015
1	BMS 641988IBA 08/2015
1	Androgen Receptor AntagonistsIBA 08/2015
1	Insulin ReceptorIBA 10/2009
1	BMS 536924IBA 10/2009
1	Protein Isoforms (Isoforms)IBA 10/2009
1	Insulin (Novolin)FDA Link 10/2009

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2019
1	Immunotherapy 01/2019